HAIC Combined Sintilimab for Liver Metastasis From Esophageal Squamous Cell Carcinoma

Clinical trial NCT06184841 · COMPLETED

Trial details

NCT number: NCT06184841
Sponsor: Peking University Cancer Hospital & Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Arterial Infusion Chemotherapy Liver Metastases Esophageal Squamous Cell Carcinoma

Start date: 2020-06-18
Primary completion: 2023-10-18
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.